Resources
51 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 1/26/2022 (updated 3/26/2024)
The Centers for Disease Control and Prevention (CDC) looked at data from six states mandated to report on neonatal abstinence syndrome (NAS), a condition that occurs when newborn babies experience withdrawal from drugs. A previous study of these states – Arizona, Florida, Georgia, Kentucky, Tennessee, and Virginia – indicated that the reporting helped determine the prevalence of NAS and identify communities more severely affected. The current report is based on answers to a follow-up questionnaire given to epidemiologists and birth defects program managers from the same six states.
Posted 8/8/2023 (updated 3/26/2024)
This webinar is an invaluable opportunity for health care professionals, policymakers, researchers, and anyone else interested in mental health and substance use interventions to learn about the latest research and innovative approaches in the field.
Posted 8/15/2023 (updated 3/26/2024)
During this webinar, Aaron Ferguson and Dr. Janan Wyatt reviewed the evidence, including the cost benefit, of MOUD, and recent research findings on how regulatory changes affect patient experience.
Posted 3/9/2022 (updated 3/27/2024)
IMPORTANCE Thousands of pregnant people with opioid use disorder (OUD) enter US jails annually,
yet their access to medications for OUD (MOUD) that meet the standard of care (methadone and/or
buprenorphine) is unknown.
OBJECTIVE To assess the availability of MOUD for the treatment of pregnant individuals with OUD
in US jails.
Posted 3/15/2022 (updated 3/27/2024)
Pre- Pregnancy fact sheet. Information for Providers
Posted 3/9/2022 (updated 3/27/2024)
The U.S. Department of Health and Human Services (HHS) together with leading clinicians, researchers, and policy experts led the development of a standard clinical definition for opioid withdrawal in infants to help improve care. It is accompanied with a set of foundational principles that outlines bioethical uses for the definition, distinctly centering around identifying clinical and supportive care needs of mothers and their infants, using an evidence-based, compassionate, and equitable approach.
Posted 7/6/2022 (updated 3/27/2024)
Investment in rural maternal care is a featured priority of the new all-of-government approach to high rates of maternal mortality across the United States. The plan announced last week stresses more staff and capabilities for rural obstetrics and increased funding of the HRSA/FORHP-supported Rural Maternity and Obstetrics Management Strategies Program. A 2019 study from the Rural Health Research Gateway found a greater number of potentially life-threatening complications with childbirth in rural areas.
Posted 5/3/2022 (updated 3/27/2024)
Buprenorphine utilization is an effective treatment for opioid use disorder (OUD). Given the recent
increase in child maltreatment reports related to parental substance use, research should explore the correlation between buprenorphine treatment and child maltreatment–related outcomes.
Posted 9/29/2023 (updated 3/27/2024)
The RCORP-TA NAS II Onboarding Packet is a tool to support the implementation of planned activities and to expand SUD/OUD services across the care spectrum thereby helping rural residents in communities to prevent SUD/OUD, access treatment, and move toward recovery.
Posted 5/10/2022 (updated 3/27/2024)
County Health Rankings & Roadmaps (CHR&R) brings actionable data, evidence, guidance, and stories to diverse leaders and residents so people and communities can be healthier. The University of Wisconsin Population Health Institute created CHR&R for communities across the nation, with funding from the Robert Wood Johnson Foundation.